Opportunity
CanadaBuys #PS27RFPFORLENALIDOMIDANDPOMALIDOMIDE
Solicitation for Oncology Lenalidomide and Pomalidomide Oral Solids for HealthPRO Canada
Posted
June 09, 2026
Respond By
July 14, 2026
Identifier
PS27RFPFORLENALIDOMIDANDPOMALIDOMIDE
NAICS
424210
HealthPRO Procurement Services Inc., a national healthcare group purchasing organization, is seeking proposals for the supply of oncology medications Lenalidomide and Pomalidomide in oral solid form. - Government Buyer: - HealthPRO Procurement Services Inc. (on behalf of Nova Scotia Health and IWK) - Products/Services Requested: - Lenalidomide Oral Solids (oncology medication) - Pomalidomide Oral Solids (oncology medication) - No specific part numbers or quantities provided - OEMs and Vendors: - No specific manufacturers or vendors named in the notice - Notable Requirements: - Contract duration is estimated at 36 months - Procurement is governed by the Canadian Free Trade Agreement (CFTA) and the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) - Participation is subject to existing HealthPRO Canada contracts - Full details are available on a third-party site
Description
HealthPRO Procurement Services Inc. is soliciting proposals for a contract involving Oncology Lenalidomide and Pomalidomide Oral Solids. The contract duration is estimated to be 36 months. This procurement is conducted under the Canadian Free Trade Agreement (CFTA) and the Canada-European Union Comprehensive Economic and Trade Agreement (CETA). Participation is subject to existing contracts and full details are available on a third-party site.